[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Waid City Hospital, Zurich\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":36},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":5},"100635639",false,"NCT07555301","Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy","SWIAN","Inclusion Criteria:\n\n* IgA Nephropathy, Use of Sparsentan\n\nExclusion Criteria:\n\n* age \\\u003C 18y","ALL","18 Years",{"count":18,"type":19},50,"ESTIMATED","OBSERVATIONAL","An observational study tracking the clinical course of patients with IgA nephropathy.",[23],"IgA Nephropathy (IgAN)","NOT_YET_RECRUITING","2026-04-21",{"date":27,"type":28},"2026-04-29","ACTUAL",{"date":30,"type":19},"2026-06-01",{"date":32,"type":19},"2029-12-31",{"name":34,"class":35},"Waid City Hospital, Zurich","OTHER",""]